Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluid Challenge Dose and Pmsf in Post-Cardiac Surgery
NCT02569008Completed
- Sponsor
- St George's, University of London
- Start
- Jan 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of Ringer-Lactat Fresenius Kabi, sponsored by St George's, University of London. Primary endpoint: Proportion of Responders by dose group at 15 months. Started Jan 2014; status: completed.
02
Drugs
Ringer-Lactat Fresenius Kabi
Beyond the preview
Go deeper on NCT02569008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02569008.